{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:53:11Z","timestamp":1779162791656,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01468-3","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T04:02:45Z","timestamp":1662177765000},"page":"915-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Features and Neuroimaging Findings of Neuropil Antibody\u2013Positive Idiopathic Sporadic Ataxia of Unknown Etiology"],"prefix":"10.1007","volume":"22","author":[{"given":"Akira","family":"Takekoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Yoshikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Urushitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8788-9089","authenticated-orcid":false,"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/brain\/awg050","volume":"126","author":"M Hadjivassiliou","year":"2003","unstructured":"Hadjivassiliou M, Gru\u00c8newald R, Sharrack B, Sanders D, Lobo A, Williamson C, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain. 2003;126:685\u201391. https:\/\/doi.org\/10.1093\/brain\/awg050.","journal-title":"Brain"},{"key":"1468_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/01.wnl.0000227891.25592.8c","volume":"67","author":"WF Abdo","year":"2006","unstructured":"Abdo WF, van de Warrenburg BPC, Munneke M, van Geel WJA, Bloem BR, Kremer HPH, et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology. 2006;67:474\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000227891.25592.8c.","journal-title":"Neurology"},{"key":"1468_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1600-0404.2008.01144.x","volume":"120","author":"M Netravathi","year":"2009","unstructured":"Netravathi M, Sathyaprabha TN, Jayalaxmi K, Datta P, Nirmala M, Pal PK. A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias. Acta Neurol Scand. 2009;120:204\u20139. https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01144.x.","journal-title":"Acta Neurol Scand"},{"key":"1468_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s12311-020-01152-4","volume":"19","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Grunewald RA, Shanmugarajah PD, Sarrigiannis PG, Zis P, Skarlatou V, et al. Treatment of primary autoimmune cerebellar ataxia with mycophenolate. The Cerebellum. 2020;19:680\u20134. https:\/\/doi.org\/10.1007\/s12311-020-01152-4.","journal-title":"The Cerebellum"},{"key":"1468_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u00f1o","year":"2014","unstructured":"Ari\u00f1o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Mar Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1011.","journal-title":"JAMA Neurol"},{"key":"1468_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.14802\/jmd.18020","volume":"11","author":"H Watanabe","year":"2018","unstructured":"Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, et al. Clinical and imaging features of multiple system atrophy: challenges for an early and clinically definitive diagnosis. J Mov Disord. 2018;11:107\u201320. https:\/\/doi.org\/10.14802\/jmd.18020.","journal-title":"J Mov Disord"},{"key":"1468_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.parkreldis.2013.07.019","volume":"19","author":"M Kanazawa","year":"2013","unstructured":"Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Parkinsonism Relat Disord. 2013;19:1149\u201351. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.07.019.","journal-title":"Parkinsonism Relat Disord"},{"key":"1468_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, de Leeuw B, Moll W, Coesmans M, Jaarsma D, et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137. https:\/\/doi.org\/10.1056\/NEJM200001063420104.","journal-title":"N Engl J Med"},{"key":"1468_CR9","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","volume":"120","author":"WP Maso","year":"1997","unstructured":"Maso WP, Graus F, Lang B, Honnorat J, Delattre JY, Valldeoriola F, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain. 1997;120:1279\u2013300. https:\/\/doi.org\/10.1093\/brain\/120.8.1279.","journal-title":"Brain"},{"key":"1468_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJM199006283222604","volume":"322","author":"HM Furneaux","year":"1990","unstructured":"Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med. 1990;322:1844\u201351. https:\/\/doi.org\/10.1056\/NEJM199006283222604.","journal-title":"N Engl J Med"},{"key":"1468_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.23550","volume":"71","author":"E de Graaff","year":"2012","unstructured":"de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta\/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71:815\u201324. https:\/\/doi.org\/10.1002\/ana.23550.","journal-title":"Ann Neurol"},{"key":"1468_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev. 2017;97:839\u201387. https:\/\/doi.org\/10.1152\/physrev.00010.2016.","journal-title":"Physiol Rev"},{"key":"1468_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717\u201320. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92.","journal-title":"Neurology"},{"key":"1468_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/WNL.0000000000004311","volume":"89","author":"I Giordano","year":"2017","unstructured":"Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, et al. Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia. Neurology. 2017;89:1043\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000004311.","journal-title":"Neurology"},{"key":"1468_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000324625.00404.15.","journal-title":"Neurology"},{"key":"1468_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.27446","volume":"33","author":"V Damato","year":"2018","unstructured":"Damato V, Balint B, Kienzler AK, Irani SR. The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord. 2018;33:1376\u201389. https:\/\/doi.org\/10.1002\/mds.27446.","journal-title":"Mov Disord"},{"key":"1468_CR17","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/wco.0000000000000678","volume":"32","author":"B Joubert","year":"2019","unstructured":"Joubert B, Honnorat J. Nonparaneoplastic autoimmune cerebellar ataxias. Curr Opin Neurol. 2019;32:484\u201392. https:\/\/doi.org\/10.1097\/wco.0000000000000678.","journal-title":"Curr Opin Neurol"},{"key":"1468_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0039-3402061","volume":"40","author":"RN Narayan","year":"2020","unstructured":"Narayan RN, McKeon A, Fife TD. Autoimmune vestibulocerebellar syndromes. Semin Neurol. 2020;40:97\u2013115. https:\/\/doi.org\/10.1055\/s-0039-3402061.","journal-title":"Semin Neurol"},{"key":"1468_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2018.04.001","volume":"319","author":"N Yoshikura","year":"2018","unstructured":"Yoshikura N, Kimura A, Fukata M, Fukata Y, Yokoi N, Harada N, et al. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies. J Neuroimmunol. 2018;319:63\u20137. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.001.","journal-title":"J Neuroimmunol"},{"key":"1468_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/mdc3.12957","volume":"7","author":"K Fuseya","year":"2020","unstructured":"Fuseya K, Kimura A, Yoshikura N, Yamada M, Hayashi Y, Shimohata T. Corticobasal syndrome in a patient with anti-IgLON5 antibodies. Mov Disord Clin Pract. 2020;7:557\u20139. https:\/\/doi.org\/10.1002\/mdc3.12957.","journal-title":"Mov Disord Clin Pract"},{"key":"1468_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0361-9230(91)90003-3","volume":"26","author":"JR Buchhalter","year":"1991","unstructured":"Buchhalter JR, Dichter MA. Electrophysiological comparison of pyramidal and stellate nonpyramidal neurons in dissociated cell culture of rat hippocampus. Brain Res Bull. 1991;26:333\u20138. https:\/\/doi.org\/10.1016\/0361-9230(91)90003-3.","journal-title":"Brain Res Bull"},{"key":"1468_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/mds.22129","volume":"23","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Boscolo S, Tongiorgi E, Gr\u00fcnewald RA, Sharrack B, Sanders DS, et al. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord. 2008;23:1370\u20137. https:\/\/doi.org\/10.1002\/mds.22129.","journal-title":"Mov Disord"},{"key":"1468_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00415-009-5262-8","volume":"257","author":"K B\u00fcrk","year":"2010","unstructured":"B\u00fcrk K, Wick M, Roth G, Decker P, Voltz R. Antineuronal antibodies in sporadic late-onset cerebellar ataxia. J Neurol. 2010;257:59\u201362. https:\/\/doi.org\/10.1007\/s00415-009-5262-8.","journal-title":"J Neurol"},{"key":"1468_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00415-011-6266-8","volume":"259","author":"R Sivera","year":"2012","unstructured":"Sivera R, Mart\u00edn N, Bosc\u00e1 I, Sevilla T, Muelas N, Azor\u00edn I, et al. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia. J Neurol. 2012;259:851\u20134. https:\/\/doi.org\/10.1007\/s00415-011-6266-8.","journal-title":"J Neurol"},{"key":"1468_CR25","first-page":"8","volume":"9","author":"M Hadjivassiliou","year":"2010","unstructured":"Hadjivassiliou M. Primary autoimmune cerebellar ataxia (PACA). Adv Clin Neurosci Rehabil. 2010;9:8\u201311.","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"1468_CR26","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12311-020-01132-8","volume":"9","author":"M Hadjivassiliou","year":"2020","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic criteria for primary autoimmune cerebellar ataxia -guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum. 2020;9:605\u201310. https:\/\/doi.org\/10.1007\/s12311-020-01132-8.","journal-title":"Cerebellum"},{"key":"1468_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40673-021-00129-1","volume":"8","author":"M Hadjivassiliou","year":"2021","unstructured":"Hadjivassiliou M, Wild G, Shanmugarajah P, Gr\u00fcnewald RA, Akil M. Indirect immunofluorescent assay as an aid in the diagnosis of suspected immune mediated ataxias. Cerebellum Ataxias. 2021;8:6. https:\/\/doi.org\/10.1186\/s40673-021-00129-1.","journal-title":"Cerebellum Ataxias"},{"key":"1468_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.1097","volume":"50","author":"C Buckley","year":"2001","unstructured":"Buckley C, Oger J, Clover L, T\u00fcz\u00fcn E, Carpenter K, Psych D, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50:73\u20138. https:\/\/doi.org\/10.1002\/ana.1097.","journal-title":"Ann Neurol"},{"key":"1468_CR29","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awh526","volume":"128","author":"BM Ances","year":"2005","unstructured":"Ances BM, Vitaliani R, Taylor RA, Liebeskind DS, Voloschin A, Houghton DJ, et al. Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain. 2005;128:1764\u201377. https:\/\/doi.org\/10.1093\/brain\/awh526.","journal-title":"Brain"},{"key":"1468_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/nejmra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018;378:840\u201351. https:\/\/doi.org\/10.1056\/nejmra1708712.","journal-title":"N Engl J Med"},{"key":"1468_CR31","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2015.2378","volume":"72","author":"AL Jones","year":"2015","unstructured":"Jones AL, Flanagan EP, Pittock SJ, Mandrekar JN, Eggers SD, Ahlskog EJ, et al. Responses to and outcomes of treatment of autoimmune cerebellar ataxia in adults. JAMA Neurol. 2015;72:1304\u201312. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2378.","journal-title":"JAMA Neurol"},{"key":"1468_CR32","doi-asserted-by":"publisher","first-page":"813926","DOI":"10.3389\/fimmu.2022.813926","volume":"13","author":"Y Jia","year":"2022","unstructured":"Jia Y, Li M, Li D, Zhang M, Wang H, Jiao L, et al. Immune-mediated cerebellar ataxia associated with neuronal surface antibodies. Front Immunol. 2022;13:813926. https:\/\/doi.org\/10.3389\/fimmu.2022.813926.","journal-title":"Front Immunol"},{"key":"1468_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24872","volume":"81","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ. Microtubule-associated protein 1B: Novel paraneoplastic biomarker. Ann Neurol. 2017;81:266\u201377. https:\/\/doi.org\/10.1002\/ana.24872.","journal-title":"Ann Neurol"},{"key":"1468_CR34","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1212\/nxi.0000000000000474","volume":"5","author":"JA Honorat","year":"2018","unstructured":"Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, et al. Autoimmune Septin-5 cerebellar ataxia. Neurol Neuroimmunol Neuroinflamm. 2018;5:e474. https:\/\/doi.org\/10.1212\/nxi.0000000000000474.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1468_CR35","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1212\/wnl.0000000000008061","volume":"93","author":"JA Honorat","year":"2019","unstructured":"Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, et al. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology. 2019;93:e954\u201363. https:\/\/doi.org\/10.1212\/wnl.0000000000008061.","journal-title":"Neurology"},{"key":"1468_CR36","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1212\/nxi.0000000000000666","volume":"7","author":"E Maudes","year":"2020","unstructured":"Maudes E, Landa J, Mu\u00f1oz-Lopetegi A, Armangue T, Alba M, Saiz A, et al. Clinical significance of Kelch-like protein 11 antibodies. Neurol Neuroimmunol Neuroinflamm. 2020;7:e666. https:\/\/doi.org\/10.1212\/nxi.0000000000000666.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1468_CR37","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaneurol.2013.1955","volume":"70","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Sabater L, Ortega A, Dalmau J, Graus F. Patient with homer-3 antibodies and cerebellitis. JAMA Neurol. 2013;70:506\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1955.","journal-title":"JAMA Neurol"},{"key":"1468_CR38","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12974-014-0206-3","volume":"11","author":"S Jarius","year":"2014","unstructured":"Jarius S, Scharf M, Begemann N, St\u00f6cker W, Probst C, Serysheva II, et al. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. J Neuroinflammation. 2014;11:206. https:\/\/doi.org\/10.1186\/s12974-014-0206-3.","journal-title":"J Neuroinflammation"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01468-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01468-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T08:37:38Z","timestamp":1694075858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01468-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01468-3","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]},"assertion":[{"value":"22 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Gifu University Graduate School of Medicine, Gifu, Japan (Protocol 2020\u2013001), and written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}